The issued patents support the ZIP implant family and technology focused on selecting orthopedic implants based on a patient’s bone density scan results.
The strategy shares the company's biomimetic implants, regenerative biomaterials, and composite polymer surgical technologies throughout the Middle East and Southeast Asia.